Progesterone receptor in estrogen receptor-positive breast cancer: The association between HER-2 and lymph node involvement is age related [3]

Journal of Clinical Oncology

Volumn 24, Issue 16, 2006, Pages 2595-

  Neven, Patrick ^a   Pochet, Nathalie ^a   Drijkoningen, Maria ^a   Amant, Frederic ^a   De Smet, Frank ^a   Paridaens, Robert ^a   Christiaens, Marie Rose ^a   Vergote, Ignace ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

BREAST CANCER; CANCER GRADING; CANCER INVASION; DISEASE COURSE; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME; AGE; BREAST TUMOR; FEMALE; LYMPH NODE; METABOLISM; NOTE; PATHOLOGY; RISK FACTOR; STATISTICAL MODEL;

AGE FACTORS; BREAST NEOPLASMS; FEMALE; HUMANS; LOGISTIC MODELS; LYMPH NODES; LYMPHATIC METASTASIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS;

EID: 33744996743     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.1334     Document Type: Letter

References (6)

1. Cui X, Schiff R, Arpino G, et al: Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. J Clin Oncol 23:7721-7735, 2005
2. Huang HJ, Neven P, Drijkoningen M, et al. Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related. Breast Cancer Res Treat 91:81-87, 2005
3. Love RR, Due NB, Havighurst TC, et al: Her-2/neu overexpression and response to oophorectomy plus tamoxifen adjuvant therapy in estrogen receptor-positive premenopausal women with operable breast cancer. J Clin Oncol 21:453-457, 2003
4. Neven P, Huang HJ, Vanspauwen R, et al: The prognostic and predictive value of the progesterone receptor in women with an oestrogen receptor positive breast cancer. Eur J Cancer 2:46-48, 2004 (suppl; abstr 16)
5. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY, John Wiley & Sons, 1989
6. Arpino G, Weiss H, Lee AV, et al: Estrogen receptor-positive, progesterone receptor-negative breast cancer: Association with growth factor receptor expression and tamoxifen resistance. J Natl Cancer Inst 97:1254-1261, 2005